Search clinical trials for: comparing platelet-rich plasma

Total 11134 results

Hospital Universitari Vall d'Hebron Research Institute

Completed

Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis

Knee Osteoarthritis

Spain
Istituto Clinico Humanitas
Istituto Ortopedico Rizzoli

Recruiting

Immuno-based Profiling of knEe OA Patients to Predict reSponse to Regenerative Treatment (IMPRESA)

Osteoarthritis, Knee

Italy
Taichung Veterans General Hospital

Not yet recruiting

The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction (PRP)

Effect of Drug | Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis)

Taiwan
Kafrelsheikh University
Helwan University

Recruiting

PRP Versus PRF Versus Conventional Treatment in Chronic Non-healing Skin Ulcers

Chronic Non-healing Skin Ulcers

Egypt
Institute of Liver and Biliary Sciences, India

Not yet recruiting

An Open-label Randomized Controlled Trial Comparing the Role of Therapeutic Plasma-exchange in Ameliorating Secondary Organ Dysfunctions in Patients With ACLF and Develop Biomarkers of Treatment Response

Acute on Chronic Liver Failure

India
Janssen Research & Development, LLC

Recruiting

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide (MonumenTAL-6)

Relapsed or Refractory Multiple Myeloma

Korea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
National Cancer Institute (NCI)

Recruiting

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
Carlos Roberto Simons-Linares

Recruiting

Comparing Reduction With ESD- Versus APC-TORe (CREATORe)

Obesity | Weight Gain | Roux-en-y Anastomosis Site

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Not yet recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

AL Amyloidosis
QC Kinetix LLC

Recruiting

Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis (PRPNSAIDsKOA)

Osteoarthritis of the Knee | Knee Pain Chronic | Degenerative Osteoarthritis

United States
RegenLab France SAS

Recruiting

Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis

Knee Osteoarthritis

France
Cochlear
Avania; QbD Clinical

Recruiting

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation (CALOS4)

Hearing Loss

Germany, Australia
Indonesia University

Recruiting

Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia

Alopecia, Androgenetic

Indonesia
Memorial Sloan Kettering Cancer Center
Paula and Rodger Riney Foundation; Plantable; M and M labs; VeggieDoctor; Sabinsa...

Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance

United States
Janssen Research & Development, LLC

Recruiting

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-9)

Relapsed or Refractory Multiple Myeloma

United States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma

United States
PETHEMA Foundation
Bristol-Myers Squibb; Sanofi; Adknoma; Start from scratch

Not yet recruiting

NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide (GEM21menos65)

Newly Diagnosed Multiple Myeloma

Spain
Octapharma

Recruiting

Active-control Randomised Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery (FARES-2)

Bleeding Cardiac Surgery Patients

Canada, United States
University Health Network, Toronto
Women's College Hospital; Cleveland Clinic Canada

Not yet recruiting

Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA (ABLE-OA)

Osteoarthritis, Knee

Canada
Janssen Research & Development, LLC

Recruiting

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment (MonumenTAL-3)

Relapsed or Refractory Multiple Myeloma

United States, Korea, Republic of, Italy, Taiwan, China, Germany, Israel, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Belgium, Greece, Netherlands
Hospital for Special Surgery, New York
Orthopedic Research and Education Foundation

Recruiting

PRP in ACLR to Prevent PTOA

Post-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | PRP

United States
Shin Kong Wu Ho-Su Memorial Hospital

Recruiting

Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment of Frozen Shoulder

Injection | Adhesive Capsulitis | Frozen Shoulder | Shoulder | Corticosteroid | Platelet-rich Plasma

Taiwan
Assistance Publique - Hôpitaux de Paris

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment. (MRD-CONFIRM)

Multiple Myeloma

France
Walter Reed National Military Medical Center
United States Naval Medical Center, San Diego; Uniformed Services University... and other collaborators

Recruiting

Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis (PRP)

Pain | Osteoarthritis of the Shoulder | Corticosteroid | PRP

United States
Faculty Hospital Kralovske Vinohrady

Not yet recruiting

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

Androgenetic Alopecia | Alopecia | Hair Loss
Alexandria University

Recruiting

Radiofrequency, Perineural Injection, Idiopathic Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Egypt
Shandong New Time Pharmaceutical Co., LTD

Recruiting

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Recruiting

China
Celgene

Recruiting

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (EXCALIBER-RRMM)

Multiple Myeloma

Austria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
University of Chicago
American Orthopaedic Society for Sports Medicine

Recruiting

Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)

Meniscal Tear

United States
University of Chile

Recruiting

Effect of Platelet-rich Plasm (PRF) on Two-implant Mandibular Overdenture: a Split Mouth (PRF)

Dental Implant Failed | Edentulous Jaw

Chile
Taipei Medical University Hospital

Recruiting

Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)

Erectile Dysfunction

Taiwan
Regenerative Orthopedics and Sports Medicine
EmCyte Corporation

Recruiting

A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis

Osteoarthritis | Osteoarthritis, Hip | Degeneration

United States
Steadman Philippon Research Institute
United States Department of Defense; Office of Naval Research (ONR)

Recruiting

Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

Osteoarthritis, Knee

United States
Immunicom Inc

Recruiting

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Advanced Breast Cancer

Poland, Turkey
Wrightington, Wigan and Leigh NHS Foundation Trust
TRB Chemedica

Recruiting

Comparing Injection Treatments for Tennis Elbow (CITTE)

Lateral Epicondylitis | Tennis Elbow | Elbows Tendonitis

United Kingdom
University of Turin, Italy

Recruiting

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Multiple Myeloma

Italy
Taipei Medical University Hospital

Recruiting

Comparing the Efficacy of Steroid, Acupuncture and Platelet Rich Plasma Injection in Patients With Sciatica

Sciatica

Taiwan
Swedish Medical Center

Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion (BEAM)

Multiple Myeloma

United States
Wake Forest University Health Sciences

Not yet recruiting

Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

Androgenic Alopecia

United States
University of Colorado, Denver
Stanford University; University of Kentucky

Recruiting

Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

Degenerative Lesion of Articular Cartilage of Knee

United States
Janssen Research & Development, LLC

Active, not recruiting

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

Multiple Myeloma

Canada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
Janssen Research & Development, LLC

Active, not recruiting

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
Janssen Research & Development, LLC

Active, not recruiting

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

Multiple Myeloma

United States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
Janssen Research & Development, LLC

Active, not recruiting

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma (CARTITUDE-4)

Multiple Myeloma

United States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
Weill Medical College of Cornell University
Eclipse Aesthetics, LLC

Completed

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Nail Diseases

United States
Amgen

Completed

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (ARROW2)

Relapsed or Refractory Multiple Myeloma

France, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
Yung-Tsan Wu

Completed

Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow

Ulnar Neuropathy at Elbow

Taiwan
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen

Completed

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Multiple Myeloma

Austria, Germany
Spero Therapeutics

Completed

A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.

Healthy Volunteer

United States
Sanofi

Active, not recruiting

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients (IKEMA)

Plasma Cell Myeloma

France, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom

3

Subscribe